Marek's Disease Virus Modulates T Cell Proliferation via Activation of Cyclooxygenase 2-Dependent Prostaglandin E2

Front Immunol. 2021 Dec 22:12:801781. doi: 10.3389/fimmu.2021.801781. eCollection 2021.

Abstract

Marek's disease virus (MDV), an avian alphaherpesvirus, infects chickens, transforms CD4+ T cells, and induces immunosuppression early during infection. However, the exact mechanisms involved in MDV-induced immunosuppression are yet to be identified. Here, our results demonstrate that MDV infection in vitro and in vivo induces activation of cyclooxygenase-2 (COX-2) and production of prostaglandin E2 (PGE2). This exerts its inhibitory effects on T cell proliferation at day 21 post infection via PGE2 receptor 2 (EP2) and receptor 4 (EP4). Impairment of the MDV-induced T cell proliferation was associated with downregulation of IL-2 and transferrin uptake in a COX-2/PGE2 dependent manner in vitro. Interestingly, oral administration of a COX-2 inhibitor, meloxicam, during MDV infection inhibited COX-2 activation and rescued T cell proliferation at day 21 post infection. Taken together, our results reveal a novel mechanism that contributes to immunosuppression in the MDV-infected chickens.

Keywords: COX2 = cyclooxygenase 2; Marek’s disease virus; PGE2; T cell proliferation; immunosuppression.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Proliferation / physiology
  • Chickens
  • Cyclooxygenase 2 / metabolism*
  • Dinoprostone / metabolism*
  • Enzyme Activation / immunology
  • Herpesvirus 2, Gallid
  • Immune Tolerance / immunology*
  • Lymphocyte Activation / immunology
  • Marek Disease / immunology*
  • Marek Disease / metabolism
  • Marek Disease / virology
  • T-Lymphocytes / immunology*

Substances

  • Cyclooxygenase 2
  • Dinoprostone